Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Dynamic of broad H3K4me3 domains uncover an epigenetic switch between cell identity and cancer-related genes
PubMed Full text in PMC Similar studies Analyze with GEO2R
ChIP-Seq targeting TLX3 in DN-TL3
PubMed Full text in PMC Similar studies SRA Run Selector
RNA-Seq in Jurkat treated with either PBIT or DMSO
PubMed Full text in PMC Similar studies Analyze with GEO2RSRA Run Selector
ChIP-Seq H3K4me3 in Jurkat treated with either OICR-9429, PBIT or DMSO
Dynamic of H3K4me3-broad domains uncover an epigenetic switch between cell identity and cancer-related genes
Broad H3K4me3 Reveals Increased Transcription Elongation and Enhancer Activity at Tumor Suppressors
The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia
RNA-sequencing of CD34+ thymocytes that were cultured on an OP9-GFP or OP9-DLL1 feeder layer.
RNA-sequencing of the GSI treatment of the CUTLL1 cell line
Development of gene expression signatures with lncRNAs for T-cell subsets (CD34+ and CD4+CD8+)
Development of gene expression signatures with lncRNAs for coculture of CD34+ T-cells with an OP9-DLL1 feeder layer
Development of gene expression signatures with lncRNAs for GSI treatment of T-ALL cell lines
Development of gene expression signatures with lncRNAs for GSI treatment of the CUTLL1 cell line.
Development of gene expression signatures with lncRNAs for 64 T-ALL patient samples
Development of gene expression signatures with lncRNAs for 15 T-ALL patients
Chromatin interactions involving super-enhancers associate with specific expression patterns of target genes
Microarray analysis of E2a-/- and E2a/-Lef1F/F leukemia lines after retroviral Cre expression
RNA-sequencing of E2a-deficient or E2a and Lef1-deficient leukemia cell lines
T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment
PubMed Full text in PMC Similar studies
Gene expression in TAL1-driven T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on